5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide

C117H108FN33O10 — CID 158538114

IUPAC5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide
SMILESCN(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccncc4)c3c2)c1.CN(C)Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(Oc5ccccc5F)nc4)c3c2)c1.CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)N(C)C)c5)cc34)cn2)CC1.Cc1cc(NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)ccn1.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(NC(=O)N4CCOCC4)c3)cc12
InChIInChI=1S/C27H23FN6O2.C26H29N9O2.C24H22N6O3.C21H19N7O2.C19H15N5O/c1-34(2)16-17-11-19(14-29-13-17)18-7-9-23-21(12-18)26(33-32-23)27(35)31-20-8-10-25(30-15-20)36-24-6-4-3-5-22(24)28;1-33(2)26(37)30-20-12-18(14-27-15-20)17-4-6-22-21(13-17)24(32-31-22)25(36)29-19-5-7-23(28-16-19)35-10-8-34(3)9-11-35;31-23(26-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)28-29-22)17-12-19(15-25-14-17)27-24(32)30-8-10-33-11-9-30;1-28(2)21(30)25-16-9-14(11-23-12-16)13-3-4-18-17(10-13)19(27-26-18)20(29)24-15-5-7-22-8-6-15;1-12-9-15(6-8-21-12)22-19(25)18-16-10-13(4-5-17(16)23-24-18)14-3-2-7-20-11-14/h3-15H,16H2,1-2H3,(H,31,35)(H,32,33);4-7,12-16H,8-11H2,1-3H3,(H,29,36)(H,30,37)(H,31,32);1-7,12-15H,8-11H2,(H,26,31)(H,27,32)(H,28,29);3-12H,1-2H3,(H,25,30)(H,26,27)(H,22,24,29);2-11H,1H3,(H,23,24)(H,21,22,25)
InChIKeyHOEOBALAQICACJ-UHFFFAOYSA-N
MW2155.37 g/mol
LogP19.07
Rot. Bonds23

About 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide

5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide (PubChem CID 158538114) has the molecular formula C117H108FN33O10 and a molecular weight of 2155.37 g/mol. Its IUPAC name is 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide.

Molecular Properties

Compound Name5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide
PubChem CID158538114
Molecular FormulaC117H108FN33O10
Molecular Weight2155.37 g/mol
Exact Mass2153.89
IUPAC Name5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide
SMILESCN(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccncc4)c3c2)c1.CN(C)Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(Oc5ccccc5F)nc4)c3c2)c1.CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)N(C)C)c5)cc34)cn2)CC1.Cc1cc(NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)ccn1.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(NC(=O)N4CCOCC4)c3)cc12
InChIInChI=1S/C27H23FN6O2.C26H29N9O2.C24H22N6O3.C21H19N7O2.C19H15N5O/c1-34(2)16-17-11-19(14-29-13-17)18-7-9-23-21(12-18)26(33-32-23)27(35)31-20-8-10-25(30-15-20)36-24-6-4-3-5-22(24)28;1-33(2)26(37)30-20-12-18(14-27-15-20)17-4-6-22-21(13-17)24(32-31-22)25(36)29-19-5-7-23(28-16-19)35-10-8-34(3)9-11-35;31-23(26-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)28-29-22)17-12-19(15-25-14-17)27-24(32)30-8-10-33-11-9-30;1-28(2)21(30)25-16-9-14(11-23-12-16)13-3-4-18-17(10-13)19(27-26-18)20(29)24-15-5-7-22-8-6-15;1-12-9-15(6-8-21-12)22-19(25)18-16-10-13(4-5-17(16)23-24-18)14-3-2-7-20-11-14/h3-15H,16H2,1-2H3,(H,31,35)(H,32,33);4-7,12-16H,8-11H2,1-3H3,(H,29,36)(H,30,37)(H,31,32);1-7,12-15H,8-11H2,(H,26,31)(H,27,32)(H,28,29);3-12H,1-2H3,(H,25,30)(H,26,27)(H,22,24,29);2-11H,1H3,(H,23,24)(H,21,22,25)
InChIKeyHOEOBALAQICACJ-UHFFFAOYSA-N
XLogP19.07
TPSA530.11 Ų
H-Bond Donors13
H-Bond Acceptors27
Rotatable Bonds23
Heavy Atoms161
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002155.37
LogP ≤ 519.07
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1027

Analyze 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide?
The IUPAC name of 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide (CID 158538114) is 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide.
What is the SMILES notation for 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide?
The canonical SMILES for 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide is CN(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccncc4)c3c2)c1.CN(C)Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(Oc5ccccc5F)nc4)c3c2)c1.CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)N(C)C)c5)cc34)cn2)CC1.Cc1cc(NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)ccn1.O=C(Nc1ccccc1)c1n[nH]c2ccc(-c3cncc(NC(=O)N4CCOCC4)c3)cc12.
What is the InChIKey of 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide?
The InChIKey is HOEOBALAQICACJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H23FN6O2.C26H29N9O2.C24H22N6O3.C21H19N7O2.C19H15N5O/c1-34(2)16-17-11-19(14-29-13-17)18-7-9-23-21(12-18)26(33-32-23)27(35)31-20-8-10-25(30-15-20)36-24-6-4-3-5-22(24)28;1-33(2)26(37)30-20-12-18(14-27-15-20)17-4-6-22-21(13-17)24(32-31-22)25(36)29-19-5-7-23(28-16-19)35-10-8-34(3)9-11-35;31-23(26-18-4-2-1-3-5-18)22-20-13-16(6-7-21(20)28-29-22)17-12-19(15-25-14-17)27-24(32)30-8-10-33-11-9-30;1-28(2)21(30)25-16-9-14(11-23-12-16)13-3-4-18-17(10-13)19(27-26-18)20(29)24-15-5-7-22-8-6-15;1-12-9-15(6-8-21-12)22-19(25)18-16-10-13(4-5-17(16)23-24-18)14-3-2-7-20-11-14/h3-15H,16H2,1-2H3,(H,31,35)(H,32,33);4-7,12-16H,8-11H2,1-3H3,(H,29,36)(H,30,37)(H,31,32);1-7,12-15H,8-11H2,(H,26,31)(H,27,32)(H,28,29);3-12H,1-2H3,(H,25,30)(H,26,27)(H,22,24,29);2-11H,1H3,(H,23,24)(H,21,22,25).
What are the key properties of 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide?
5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide has a molecular weight of 2155.37 g/mol, XLogP of 19.07, 23 rotatable bonds, 13 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-[(dimethylamino)methyl]-3-pyridinyl]-N-[6-(2-fluorophenoxy)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;N-(2-methyl-4-pyridinyl)-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[5-[3-(phenylcarbamoyl)-1H-indazol-5-yl]-3-pyridinyl]morpholine-4-carboxamide is sourced from PubChem (CID 158538114), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).